Preoperative liquid biopsy for EGFR-mutated detection at diagnostic in early-stage non-small cell lung cancer: real-world experience of a single centre

被引：0
|
作者：
Bontoux, Christophe [1 ,2 ,3 ,4 ]
Benzaquen, Jonathan [4 ,5 ]
Taly, Valerie [6 ,7 ]
Baures, Aurelia [7 ]
Allegra, Maryline [2 ,3 ]
Lacoux, Caroline [2 ,3 ]
Tanga, Virginie [2 ,3 ]
Rignol, Guylene [2 ,3 ]
Berthet, Jean-Philippe [8 ]
Marquette, Charles-Hugo [4 ,5 ]
Lespinet-Fabre, Virginie [2 ,3 ]
Bordone, Olivier [2 ,3 ]
Goffinet, Samantha [2 ,3 ]
Ilie, Marius [2 ,3 ,4 ]
Hofman, Veronique [2 ,3 ,4 ]
Hofman, Paul [2 ,3 ,4 ]
机构：
[1] Canc Univ Inst Toulouse Oncopole, Dept Pathol, 1 Ave Irene Joliot Curie, F-31100 Toulouse, France
[2] Univ Cote Azur, CHU Nice, Hop Pasteur, Lab Clin & Expt Pathol,IHU RespirERA,FHU OncoAge, F-06001 Nice 1, France
[3] CHU Nice, Hosp Integrated Biobank BB 0033 00025, F-06001 Nice 1, France
[4] CNRS, Inst Res Canc & Aging Nice IRCAN, Team 4, UMR7284,Inserm,U1081, F-06107 Nice 2, France
[5] Univ Cote Azur, Pasteur Hosp, Dept Pneumol, IHU respirERA,FHU OncoAge,CHU Nice, F-06001 Nice 1, France
[6] Univ Paris, Ctr Rech Cordeliers, Equipe Labelisee Ligue Natl Canc, UMR S1138,CNRS,SNC5096, Paris, France
[7] METHYS DxFrance, 67 rue St Jacques, F-75005 Paris, France
[8] Univ Cote Azur, Pasteur Hosp, Dept Thorac Surg, IHU respirERA,FHU OncoAge,CHU Nice, F-06001 Nice 1, France
来源：
JOURNAL OF CLINICAL PATHOLOGY | 2025年
关键词：
EGFR; Lung Neoplasms; Pathology; Molecular; ONCOGENES; Diagnostic Techniques and Procedures;
D O I：
10.1136/jcp-2024-209941
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] EGFR Mutations and PD-L1 Expression in Early-Stage Non-Small Cell Lung Cancer: A Real-World Data From a Single Center in Brazil
    Pinto, Icaro Alves
    Cavagna, Rodrigo de Oliveira
    Virginio da Silva, Aline Larissa
    Dias, Josiane Mourao
    Santana, Iara Vidigal
    Souza, Laisa Caroline
    Ferreira da Silva, Flavio Augusto
    Biazotto Fernandes, Maria Fernanda
    Junqueira Pinto, Gustavo Dix
    Negreiros, Izabella Santos
    Santiago Goncalves, Maria Fernanda
    de Paula, Flavia Escremim
    Berardinelli, Gustavo Noriz
    Stanfoca Casagrande, Giovanna Maria
    da Silva, Marcela Oliveira
    Albino da Silva, Eduardo Caetano
    de Oliveira, Marco Antonio
    Jacinto, Alexandre Arthur
    da Silva, Vinicius Duval
    Reis, Rui Manuel
    De Marchi, Pedro
    Leal, Leticia Ferro
    ONCOLOGIST, 2022, 27 (11): : E899 - E907
  • [42] Role of TP53 Mutations and EGFR Amplification in Risk Stratification of Early-Stage EGFR-Mutated Non-Small Cell Lung Cancer With Immunohistochemistry as a Surrogate Marker
    Kim, Meejeong
    Park, Gyeong Sin
    Lee, Kyo Young
    Moon, Seok Whan
    Sung, Yeoun Eun
    THORACIC CANCER, 2025, 16 (07)
  • [43] Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer
    Choi, Yu-Ra
    Kang, Eun Hye
    Kim, Sunshin
    Park, Seog-Yun
    Han, Ji-Youn
    Lee, Youngjoo
    BRITISH JOURNAL OF CANCER, 2023, 128 (12) : 2186 - 2196
  • [44] Single targeting of MET in EGFR-mutated and MET-amplified non-small cell lung cancer
    Yu-Ra Choi
    Eun Hye Kang
    Sunshin Kim
    Seog‑Yun Park
    Ji-Youn Han
    Youngjoo Lee
    British Journal of Cancer, 2023, 128 : 2186 - 2196
  • [45] Real-World Outcomes of Patients with Resectable Early-Stage Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemoimmunotherapy
    Hazim, A.
    Xiao, A.
    Singh, A.
    Chung, K.
    dos Santos, P. A. Reck
    D'Cunha, J.
    Shanshal, M.
    Dimou, A.
    Parikh, K.
    Lou, Y.
    Manochakian, R.
    Leventakos, K.
    Molina, J.
    Mansfield, A.
    Ernani, V.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S546 - S547
  • [46] Diagnostic therapeutic pathway (DTP) of early stage non-small cell lung cancer (eNSCLC): A real-world focus on EGFR status detection in resected patients (pts)
    Pasello, G.
    Lorenzi, M.
    Pretelli, G.
    Pezzuto, F.
    Comacchio, G.
    Buja, A.
    Bonanno, L.
    Guarneri, V.
    Conte, P. F.
    Rea, F.
    Calabrese, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S933 - S933
  • [47] Repeated biopsy for mutational analysis on EGFR-mutated non-small cell lung cancer (EGFR-NSCLC): Feasibility and safety
    Anguera, G.
    Riudavets, M.
    Torrego, A.
    Pajares, V.
    Gimenez, A.
    Lopez-Vilaro, L.
    Martinez, E.
    Trujillo-Reyes, J. C.
    Lerma, E.
    Majem, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Real-World T790M Mutation Frequency and Impact of Rebiopsy in Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer
    Pereira, Isabel
    Gaspar, Catia
    Pina, Marta
    Azevedo, Isabel
    Rodrigues, Ana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
  • [49] Economic evaluation of adjuvant therapy with osimertinib in patients with early-stage non-small cell lung cancer and mutated EGFR
    Perez, Alejandro Vila
    Alegre-del Rey, Emilio J.
    Fenix-Caballero, Silvia
    Spacirova, Zuzana
    Varela, Petra Rosado
    Lima, Antonio Olry de Labry
    SUPPORTIVE CARE IN CANCER, 2024, 32 (01)
  • [50] EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada
    Kuruvilla, M. Sara
    Liu, Geoffrey
    Syed, Iqra
    Gwadry-Sridhar, Femida
    Sheffield, Brandon S.
    Sachdeva, Robin
    Pencz, Alec
    Zhan, Luna
    Hueniken, Katrina
    Patel, Devalben
    Balaratnam, Karmugi
    Khan, Khaleeq
    Grant, Benjamin
    Noy, Shawna
    Singh, Karan
    Liu, Linda
    Rakibuz-Zaman, Muhammad
    Moldaver, Daniel
    Shanahan, Mary Kate
    Cheema, Parneet K.
    LUNG CANCER, 2022, 173 : 58 - 66
12345